| Product Code: ETC6528054 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a sharp decline in the Compound Annual Growth Rate (CAGR) from 2020-2024 and a significant drop in the growth rate from 2023-2024, Brunei continues to rely heavily on imports of guanylate cyclase-c agonists, with top exporting countries including China, Germany, India, Japan, and Malaysia. The high concentration level, as indicated by the Herfindahl-Hirschman Index (HHI), in 2024 suggests a market dominated by a few key players. The industry may face challenges in the near future, but these import trends highlight the ongoing demand for such pharmaceutical products in Brunei.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Guanylate Cyclase-C Agonists Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Guanylate Cyclase-C Agonists Market - Industry Life Cycle |
3.4 Brunei Guanylate Cyclase-C Agonists Market - Porter's Five Forces |
3.5 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.6 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.8 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brunei Guanylate Cyclase-C Agonists Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases in Brunei |
4.2.2 Growing awareness about the benefits of guanylate cyclase-c agonists in treating gastrointestinal disorders |
4.2.3 Rising healthcare expenditure and infrastructure development in Brunei |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Brunei |
4.3.2 Limited availability of guanylate cyclase-c agonists in the market |
4.3.3 High cost associated with guanylate cyclase-c agonists treatment |
5 Brunei Guanylate Cyclase-C Agonists Market Trends |
6 Brunei Guanylate Cyclase-C Agonists Market, By Types |
6.1 Brunei Guanylate Cyclase-C Agonists Market, By Drug |
6.1.1 Overview and Analysis |
6.1.2 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Drug, 2021- 2031F |
6.1.3 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Trulance, 2021- 2031F |
6.1.4 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Linzess, 2021- 2031F |
6.2 Brunei Guanylate Cyclase-C Agonists Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Irritable Bowel Syndrome, 2021- 2031F |
6.2.3 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Chronic Idiopathic Constipation, 2021- 2031F |
6.2.4 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Brunei Guanylate Cyclase-C Agonists Market, By Dosage |
6.3.1 Overview and Analysis |
6.3.2 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Tablet, 2021- 2031F |
6.3.4 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Brunei Guanylate Cyclase-C Agonists Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.4 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Brunei Guanylate Cyclase-C Agonists Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Brunei Guanylate Cyclase-C Agonists Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Brunei Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
7 Brunei Guanylate Cyclase-C Agonists Market Import-Export Trade Statistics |
7.1 Brunei Guanylate Cyclase-C Agonists Market Export to Major Countries |
7.2 Brunei Guanylate Cyclase-C Agonists Market Imports from Major Countries |
8 Brunei Guanylate Cyclase-C Agonists Market Key Performance Indicators |
8.1 Patient adherence rate to guanylate cyclase-c agonists treatment |
8.2 Number of healthcare providers prescribing guanylate cyclase-c agonists |
8.3 Rate of successful clinical trials for new guanylate cyclase-c agonists treatments |
9 Brunei Guanylate Cyclase-C Agonists Market - Opportunity Assessment |
9.1 Brunei Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.2 Brunei Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Brunei Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.4 Brunei Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Brunei Guanylate Cyclase-C Agonists Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Brunei Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brunei Guanylate Cyclase-C Agonists Market - Competitive Landscape |
10.1 Brunei Guanylate Cyclase-C Agonists Market Revenue Share, By Companies, 2024 |
10.2 Brunei Guanylate Cyclase-C Agonists Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here